The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation
Physiology & Behavior · 2023
DOI: 10.1016/j.physbeh.2023.114134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiology & Behavior, 2023. Verfasst von Bo Pang und 4 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tia…. Hauptthemen laut MEDLINE: Alzheimer Disease, Sodium-Glucose Transporter 2 Inhibitors, Symporters. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China; Tianjin Key Laboratory of Metabolic Diseases, Tian…
- Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Zitieren
APA
Pang, B., Zhang, L. L., Li, B., Sun, F. X., & Wang, Z. D. (2023). The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior. https://doi.org/10.1016/j.physbeh.2023.114134
Vancouver
Pang B, Zhang LL, Li B, Sun FX, Wang ZD. The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior. 2023. doi:10.1016/j.physbeh.2023.114134
BibTeX
@article{Pang2023,
author = {Pang, Bo and Zhang, Lu-Lu and Li, Bin and Sun, Feng-Xian and Wang, Zhi-Da},
title = {The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation},
journal = {Physiology & Behavior},
year = {2023},
doi = {10.1016/j.physbeh.2023.114134}
}
EUVIMED